The State of Ohio is working with various healthcare leaders, stakeholders, and medical professionals to identify promising treatment practices, including Medication Assisted Treatment (MAT), for opioid dependent pregnant mothers eligible for or enrolled in Medicaid during and after pregnancy. Over two years, the State will invest over $2 million to improve health outcomes for these moms and their babies.

Pregnant women who are opioid dependent are at risk for negative birth outcomes. In addition, opioid addiction puts these women at risk for violence, hepatitis, HIV and other infections that can have significant health impacts on both mom and baby. In Ohio, the majority of opioid-dependent pregnant women are not engaged in prenatal treatment, though evidence-based treatment practices are known. Evidence-based practices involve opiate maintenance treatment, which is safer to the baby than stopping opiate use during pregnancy, due to the high risk of relapse and stress on the baby. Opioid maintenance also enhances the ability of women to participate in prenatal care and addiction treatment.

The goal of this collaborative, called Maternal Opiate Medical Supports (MOMS), is to improve maternal and fetal health outcomes, improve family stability, and reduce costs of Neonatal Abstinence Syndrome (NAS) to Ohio's Medicaid program by providing treatment to pregnant mothers with opiate issues during and after pregnancy through a Maternity Care Home (MCH) model of care. The MCH model is a team based healthcare delivery model that emphasizes care coordination and wrap-around services engaging expecting mothers in a combination of counseling, MAT, and case management.

To achieve these goals, a Statewide Clinical Advisory Panel has developed a toolkit, which sets forth guidelines and best practices for establishing a Maternal Care Home for opioid dependent pregnant women in Ohio. In four pilot sites across the state, teams of healthcare professionals will utilize the tool kit to identify processes in their practices that can be improved. The following pilot site communities were selected for participation:

  • CompDrug
  • First Step Home
  • Health Recovery Services
  • MetroHealth Medical Center